Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T L T A Jansen

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
The Netherlands Journal of Medicine|April 9, 2005
Tonsillar tuberculosis in a rheumatoid arthritis patient receiving anti-TNFalpha (adalimumab) treatmentM N Efde, P M Houtman, J P L Spoorenberg, et al.
Annals of the Rheumatic Diseases|September 4, 2004
Therapeutic drug monitoring of A77 1726, the active metabolite of leflunomide: serum concentrations predict response to treatment in patients with rheumatoid arthritisE N van Roon, T L T A Jansen, M A F J van de Laar, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
The Netherlands Journal of Medicine|April 9, 2005
Tonsillar tuberculosis in a rheumatoid arthritis patient receiving anti-TNFalpha (adalimumab) treatmentM N Efde, P M Houtman, J P L Spoorenberg, et al.
Annals of the Rheumatic Diseases|September 4, 2004
Therapeutic drug monitoring of A77 1726, the active metabolite of leflunomide: serum concentrations predict response to treatment in patients with rheumatoid arthritisE N van Roon, T L T A Jansen, M A F J van de Laar, et al.
Pageof 1